Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer
Yong Gu Lee(Parker Institute for Cancer Immunotherapy), Marco Ruella(Parker Institute for Cancer Immunotherapy), Ruchi P. Patel(University of Pennsylvania), Nicholas Yang(Parker Institute for Cancer Immunotherapy), Elise A. Chong(Hospital of the University of Pennsylvania), Xueqing Maggie Lu(Parker Institute for Cancer Immunotherapy), Seok Jae Hong(Parker Institute for Cancer Immunotherapy), Hatcher J. Ballard(University of Pennsylvania), Joseph A. Fraietta(University of Pennsylvania), Guido Ghilardi(Hospital of the University of Pennsylvania), Saar Gill(Parker Institute for Cancer Immunotherapy), James N. Gerson(UPMC Hillman Cancer Center), S. Church(Nanostring Technologies (United States)), Kimberly V. Amelsberg(Hospital of the University of Pennsylvania), Simon F. Lacey(University of Pennsylvania), Puneeth Guruprasad(Parker Institute for Cancer Immunotherapy), Sara Cherry(California University of Pennsylvania), Katherine D. Cummins(Parker Institute for Cancer Immunotherapy), Inkook Chun(Parker Institute for Cancer Immunotherapy), Kanupriya Whig(University of Pennsylvania), Patrizia Porazzi(Hospital of the University of Pennsylvania), Wan-Jung Chang(Parker Institute for Cancer Immunotherapy), C Sauter(Parker Institute for Cancer Immunotherapy), D. Schultz(University of Evansville), Khrystyna North(Nanostring Technologies (United States)), Stephen J. Schuster(Hospital of the University of Pennsylvania), Raymone Pajarillo(Hospital of the University of Pennsylvania), Yunlin Zhang(Hospital of the University of Pennsylvania), Jakub Svoboda(UPMC Hillman Cancer Center)
Cited by 98
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins
|Genes & Development|2002|1.3k
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
|Immunity|2016|1.1k
An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer
|American Journal of Hematology|2019|608